ADGM (Adagio Medical Holdings) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Adagio Medical Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Adagio Medical Holdings's Free Cash Flow for the three months ended in Dec. 2024 was $0.00 Mil. Adagio Medical Holdings's Revenue for the three months ended in Dec. 2024 was $0.00 Mil. Therefore, Adagio Medical Holdings's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Adagio Medical Holdings's current FCF Yield % is -122.99%.

The historical rank and industry rank for Adagio Medical Holdings's FCF Margin % or its related term are showing as below:

ADGM' s FCF Margin % Range Over the Past 10 Years
Min: -13473.08 Med: -8664 Max: -7621.85
Current: -13473.08

During the past 4 years, the highest FCF Margin % of Adagio Medical Holdings was -7621.85%. The lowest was -13473.08%. And the median was -8664.00%.

ADGM's FCF Margin % is ranked worse than
98.67% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: -3.52 vs ADGM: -13473.08

Adagio Medical Holdings FCF Margin % Historical Data

The historical data trend for Adagio Medical Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagio Medical Holdings FCF Margin % Chart

Adagio Medical Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

FCF Margin %

-7,621.85

-12,123.81

-8,664.00

Adagio Medical Holdings Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial					-9,116.67	-26,542.31	-	-	-

Competitive Comparison of Adagio Medical Holdings's FCF Margin %

For the Medical Devices subindustry, Adagio Medical Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adagio Medical Holdings's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adagio Medical Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Adagio Medical Holdings's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Adagio Medical Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Adagio Medical Holdings's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	0	/	0
	=	%

Adagio Medical Holdings's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0	/	0
	=	%

Adagio Medical Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Adagio Medical Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Adagio Medical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adagio Medical Holdings Inc (NAS:ADGM) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

26051 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653

Website

https://www.adagiomedical.com

Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.